Prof. Dr. Roberto G Carbone | Therapeutic Management | Best Researcher Award
Professor of Medicine | University of Genoa | Italy
Prof. Roberto G Carbone is a distinguished Professor of Medicine and Senior Consultant for Interstitial Lung Disease and Pulmonary Hypertension at the University of Genoa, Italy. With decades of experience, his expertise has significantly advanced respiratory medicine through clinical practice, international education, and research. He is a Fellow of the Royal Society of Medicine and of the American College of Chest Physicians. He has been a leading member of international organizations such as the American Thoracic Society and the European Respiratory Society. Prof. Carbone has authored scientific publications and several books on pulmonary vascular disorders and lung transplantation. He is actively involved in editing leading medical journals, including The Lancet and Frontiers in Pulmonary Medicine. His clinical and academic leadership has had a profound global impact on improving outcomes for patients with complex pulmonary diseases. His ongoing research in idiopathic pulmonary fibrosis positions him as a global pioneer in respiratory medicine.
Professional Profile
Scopus
ORCID
Education
Prof. Roberto G Carbone completed his medical degree at the University of Genoa, where he also obtained two specializations in Respiratory Diseases and Respiratory Pathophysiology. He pursued advanced international education, including a Master’s degree in Respiratory Medicine from the Royal Brompton Hospital in London, United Kingdom. Additionally, he completed several specialized master programs: Pulmonary Hypertension at the University of Michigan, Ann Arbor (USA); Bronchial Asthma at National Jewish Health, Denver (USA); and COPD and Interstitial Lung Diseases at the University of Montpellier, France. He is registered with the General Medical Council in the United Kingdom and maintains long-standing memberships in prominent medical societies including the American Thoracic Society and European Respiratory Society. His diverse educational background across multiple countries and centers of excellence has equipped him with a comprehensive and multidisciplinary perspective in respiratory medicine.
Experience
Prof. Carbone high-level academic and clinical experience in respiratory medicine. He has been a key faculty member at the University of Genoa School of Medicine, serving as Senior Consultant for Interstitial Lung Disease and Pulmonary Hypertension. Internationally recognized, he has held numerous leadership positions, including within the American Thoracic Society’s COPD Steering Committee and the National Quality Forum in the United States. He has been a long-time member of the Editorial Board of CHEST Journal and has contributed to steering committees for lung transplant and cardiovascular disease. He has also been a frequent faculty member or chair at major global medical conferences, shaping discourse on respiratory diseases. His professional affiliations extend to the American College of Chest Physicians, Royal Society of Medicine, and American Heart Association, reflecting a broad and influential career in respiratory health.
Research Interests
Prof. Carbone’s research is centered on Interstitial Lung Disease (ILD), Pulmonary Hypertension (PH), Lung Cancer, Connective Tissue Diseases, Sarcoidosis, Systemic Sclerodermia, and Lung Transplantation. He has been instrumental in developing diagnostic frameworks and treatment approaches for idiopathic pulmonary fibrosis and pulmonary vascular disorders. His work integrates clinical data, molecular biology, and genomics to identify early biomarkers and improve therapeutic outcomes. Currently, he leads the Global Genome Project for Idiopathic Pulmonary Fibrosis in collaboration with the University of Denver, USA. He also contributes to guideline development and multicenter clinical trials in the areas of COPD and ILD. His work on porto-pulmonary hypertension and hepato-pulmonary syndrome has provided a better understanding of these complex syndromes and their treatment options, including the role of lung and liver transplantation. His interdisciplinary research continues to influence global standards in respiratory care and medical education.
Awards
Prof. Carbone has received several notable recognitions throughout his career. He has been consistently selected for leadership roles in top respiratory organizations, including the American Thoracic Society and the National Quality Forum. He has received multiple invitations to chair and deliver keynote lectures at international conferences, reflecting his reputation as a thought leader in pulmonary medicine. His contributions to guideline development and editorial leadership have been recognized with appointments to several prestigious journal boards, including The Lancet and CHEST. These honors reflect his sustained excellence in clinical practice, academic contribution, and research innovation in the field of respiratory medicine.
Top Noted Publications
Prof. Carbone has authored over peer-reviewed articles, with recent high-impact work published in The Lancet and CHEST. His publications focus on idiopathic pulmonary fibrosis, pulmonary hypertension, lung transplantation, and systemic scleroderma. He has also edited five authoritative books, including:
Title: Pulmonary Vascular Disorders
Journal: The Lancet
Citation Count: 123 articles
Year: 2023
Title: Interstitial Lung Disease
Journal: Frontiers in Pulmonary Medicine
Citation Count: 88 articles
Year: 2022
Title: Pulmonary Hypertension in ILD
Journal: CHEST Journal
Citation Count: 95 articles
Year: 2021
Conclusion
Professor Roberto G Carbone is eminently suitable for the Best Researcher Award. His sustained research excellence, global collaborations, and editorial leadership position him as a leader in respiratory and pulmonary medicine. Minor enhancements in reporting academic metrics and mentorship activities could further elevate his candidacy. Nonetheless, his track record reflects the hallmarks of an impactful and visionary medical researcher, fully deserving of this international recognition.